EcoDrugPlus

Histone Deacetylase 4

Ensembl ID : ENSTTRG00000003145
Gene Symbol: HDAC4
1 Cross references
263 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSTTRG00000010455
Gene Symbol: HDAC5
1 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSTTRG00000004685
Gene Symbol: HDAC6
1 Cross references
183 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSTTRG00000012577
Gene Symbol: HDAC7
1 Cross references
260 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSTTRG00000003469
Gene Symbol: HDAC8
1 Cross references
202 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSTTRG00000014890
Gene Symbol: HDAC9
1 Cross references
234 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSTTRG00000015682
Gene Symbol: HCN4
1 Cross references
287 Possible Orthologues:

Hypocretin Receptor 1

Ensembl ID : ENSTTRG00000013273
Gene Symbol: HCRTR1
1 Cross references
96 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSTTRG00000000746
Gene Symbol: HCRTR2
3 Cross references
201 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSTTRG00000010992
Gene Symbol: IDO1
1 Cross references
98 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSTTRG00000002282
Gene Symbol: IKBKB
1 Cross references
197 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSTTRG00000014598
Gene Symbol: IMPDH1
1 Cross references
330 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).